Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
61 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
36 (3%)
Resolved:
1223 (93%)
1320
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
283 (99%)
Reversed:
2 (1%)
287
211 (13%)
35 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-05-09 | 2019-09-12 | 83684 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-05-09 | 2020-09-18 | 83687 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-28 | 2019-09-03 | 87956 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87965 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87968 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90464 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2017-09-07 | 2017-10-11 | 21551 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2017-09-07 | 2018-04-19 | 21554 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2017-09-07 | 2018-04-19 | 21558 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-11-15 | 2021-06-18 | 98811 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2021-12-08 | 2023-06-09 | 150725 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2024-12-04 | 2024-12-20 | 244825 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2025-02-05 | 2025-04-01 | 249588 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2024-08-23 | 2024-09-30 | 235745 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-11 | 2019-09-04 | 86225 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-28 | 2020-09-18 | 87959 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-24 | 2018-04-27 | 4213 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-24 | 2017-09-19 | 4216 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149400 |
| PMS-ERLOTINIB | 150MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149371 |
| PMS-ERLOTINIB | 100MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149368 |
| PMS-ESOMEPRAZOLE DR | 40MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-15 | 2021-10-27 | 117909 |
| PMS-FAMCICLOVIR | 125MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149412 |
| PMS-FAMCICLOVIR | 125MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117852 |
| PMS-FAMCICLOVIR | 250MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117855 |
| PMS-FAMCICLOVIR | 500MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117858 |
| PMS-FENTANYL MTX | 12MCG | PATCH | Discontinued | 2022-07-25 | 2022-11-25 | 165462 |
| PMS-FENTANYL MTX | 75MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158296 |
| PMS-FENTANYL MTX | 50MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158299 |
| PMS-FENTANYL MTX | 100MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158293 |
| PMS-FENTANYL MTX | 25MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158304 |
| PMS-FENTANYL MTX | 12MCG | PATCH | Discontinued | 2022-07-25 | 2022-11-25 | 165397 |
| PMS-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6051 |
| PMS-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-10-12 | 2017-10-12 | 25717 |
| PMS-GABAPENTIN | 600MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117796 |
| PMS-GABAPENTIN | 800MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117801 |
| PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147352 |
| PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147347 |